CH
TMO icon

Canton Hathaway’s Thermo Fisher Scientific TMO Stock Holding History

Canton Hathaway’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Hold
2,271
– – 0.22% 56
2026
Q1 		$1.12M Hold
2,271
– – 0.23% 55
2025
Q4 		$1.32M Hold
2,271
– – 0.25% 48
2025
Q3 		$1.1M Hold
2,271
– – 0.21% 56
2025
Q2 		$921K Hold
2,271
– – 0.19% 60
2025
Q1 		$1.13M Buy
2,271
+1,200
+112% +$650K 0.23% 49
2024
Q4 		$557K Hold
1,071
– – 0.14% 57
2024
Q3 		$662K Hold
1,071
– – 0.17% 54
2024
Q2 		$592K Hold
1,071
– – 0.16% 57
2024
Q1 		$622K Hold
1,071
– – 0.17% 54
2023
Q4 		$568K Hold
1,071
– – 0.17% 54
2023
Q3 		$542K Sell
1,071
-21
-2% -$11.2K 0.17% 53
2023
Q2 		$570K Hold
1,092
– – 0.18% 52
2023
Q1 		$629K Hold
1,092
– – 0.21% 50
2022
Q4 		$601K Hold
1,092
– – 0.21% 52
2022
Q3 		$554K Hold
1,092
– – 0.2% 60
2022
Q2 		$593K Hold
1,092
– – 0.21% 59
2022
Q1 		$645K Sell
1,092
-83
-7% -$47.7K 0.18% 62
2021
Q4 		$784K Hold
1,175
– – 0.21% 61
2021
Q3 		$671K Buy
1,175
+98
+9% +$53.8K 0.19% 69
2021
Q2 		$543K Buy
1,077
+166
+18% +$78.3K 0.16% 70
2021
Q1 		$416K Buy
911
+70
+8% +$33.4K 0.13% 78
2020
Q4 		$392K Buy
841
+40
+5% +$18.8K 0.13% 80
2020
Q3 		$354K Hold
801
– – 0.15% 64
2020
Q2 		$290K Hold
801
– – 0.19% 59
2020
Q1 		$227K Sell
801
-245
-23% -$77.3K 0.16% 57
2019
Q4 		$340K Buy
1,046
+150
+17% +$45.5K 0.17% 63
2019
Q3 		$261K Buy
896
+83
+10% +$23.8K 0.14% 71
2019
Q2 		$239K Sell
813
-340
-29% -$93.6K 0.13% 75
2019
Q1 		$315K Buy
1,153
+663
+135% +$165K 0.18% 56
2018
Q4 		$110K Buy
490
+235
+92% +$55.1K 0.07% 87
2018
Q3 		$62K Buy
+255
New +$58.7K 0.04% 92

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Canton Hathaway's TMO Position: Q2 2026 in Review

Canton Hathaway held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,271 shares worth $1.14M. The position accounts for 0.22% of the portfolio, ranked #56.

Canton Hathaway first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.32M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Canton Hathaway held 2,271 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
  • Canton Hathaway left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.22% of Canton Hathaway's portfolio in Q2 2026, its #56 holding.
  • Canton Hathaway first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
  • Canton Hathaway's Thermo Fisher Scientific position peaked at $1.32M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.